Detalhe da pesquisa
1.
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.
Nat Commun
; 15(1): 974, 2024 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38321023